Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Maintenance Study Evaluating the Long Term Safety of XL999 Administered Intravenously to Subjects With Advanced Malignancies Previously Enrolled in Other XL999 Studies

NCT00955084 is registered in ClinicalTrials.gov with Symphony Evolution, Inc. as lead sponsor.

NCT NCT00955084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00955084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Maintenance Study Evaluating the Long Term Safety of XL999 Administered Intravenously to Subjects With Advanced Malignancies Previously Enrolled in Other XL999 Studies
Lead sponsor
Symphony Evolution, Inc.
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2008
Completion date
May 31, 2010
Enrollment
2 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

advanced malignancies